What is the recommended dose of Macrobid (nitrofurantoin) for treating urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Macrobid Dosing for UTI

For uncomplicated urinary tract infections in women, the recommended dose of Macrobid (nitrofurantoin monohydrate/macrocrystals) is 100 mg twice daily for 5 days. 1, 2

Standard Dosing Regimens

First-Line Treatment in Women

  • Nitrofurantoin monohydrate/macrocrystals (Macrobid): 100 mg twice daily for 5 days is the preferred first-line regimen recommended by both the Infectious Diseases Society of America and the European Association of Urology 1, 2, 3
  • Alternative nitrofurantoin formulations include:
    • Nitrofurantoin macrocrystals: 50-100 mg four times daily for 5 days 1
    • Nitrofurantoin macrocrystals prolonged release: 100 mg twice daily for 5 days 1

Treatment Duration Considerations

  • The 5-day regimen is optimal and consistently recommended across major guidelines, balancing efficacy with minimizing adverse effects and resistance development 2, 3
  • A 7-day course may be considered for treatment failures or when symptoms persist, but should not routinely exceed 7 days 2
  • The UK's 3-day recommendation lacks direct supporting evidence and is not endorsed by major international guidelines 4

Treatment in Men

  • For men with uncomplicated UTI, use 100 mg twice daily for 7 days based on limited observational data 2
  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days is an alternative first-line option in men 1

Efficacy Data

  • Clinical cure rates range from 88-93% for uncomplicated UTIs in women 2
  • Bacterial cure rates range from 81-92% 2
  • Nitrofurantoin demonstrates equivalent efficacy to trimethoprim-sulfamethoxazole and ciprofloxacin when comparing appropriate duration regimens 2

Critical Contraindications and Precautions

Renal Function

  • Nitrofurantoin is contraindicated when creatinine clearance is <60 mL/min due to inadequate urinary drug concentrations and increased toxicity risk, including peripheral neuropathy 5
  • For patients with CrCl <60 mL/min, consider alternative agents such as trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days or fosfomycin trometamol 3 g single dose 5
  • One small study suggested possible efficacy with CrCl 30-60 mL/min, but this contradicts guideline recommendations and should not change practice 6

Clinical Situations Where Nitrofurantoin Should NOT Be Used

  • Do not use if pyelonephritis is suspected (upper tract infection) 2
  • Avoid in patients with perinephric abscess 2
  • Not recommended in pregnancy (first trimester concerns with trimethoprim alternatives) 1

Special Populations

Pediatric Dosing

  • Children ≥12 years: 100 mg twice daily for 7 days 2
  • Children <12 years: 5-7 mg/kg/day divided into 4 doses (maximum 100 mg/dose) for 7 days 2

Vancomycin-Resistant Enterococci (VRE)

  • For VRE uncomplicated UTIs: 100 mg four times daily 2

Follow-Up Recommendations

  • Routine post-treatment cultures are NOT indicated for asymptomatic patients 2
  • For women whose symptoms do not resolve by end of treatment or recur within 2 weeks, perform urine culture with susceptibility testing 1, 2
  • If retreatment is needed, assume the organism is not susceptible to the original agent and use a different antibiotic for 7 days 1

Common Pitfalls to Avoid

  • Do not prescribe nitrofurantoin without checking renal function - this is the most common and dangerous error 5
  • Do not use for complicated UTIs or suspected upper tract infections 2
  • Do not extend treatment beyond 7 days unless symptoms persist, as this increases adverse effects without improving efficacy 2
  • Be aware that nausea and headache are the most common side effects, occurring in 5.6-34% of patients 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Guideline

Nitrofurantoin Dosing Considerations in Adults with UTIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.